[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-360410-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-360410-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","disrupting-srsf10-dependent-bcat2-exon-skipping-reprograms-tumor-associated-macrophages-and-enhances-antipd-1-efcacy-in-gastric-cancer","Disrupting SRSF10-dependent BCAT2 exon skipping reprograms tumor-associated macrophages and enhances antiPD-1 efﬁcacy in gastric cancer","","Immune checkpoint inhibitors improve cancer outcomes, yet many patients develop primary or acquired resistance, with gastric cancer showing marked variability in immunotherapy responsiveness. Tumor-associated macrophages in the immunosuppressive tumor microenvironment block effective immune activation through distinct M2 and M1 programs. The study highlights transcriptional reprogramming via alternative splicing as a clinically relevant resistance-associated gene signature, focusing on SRSF10-dependent BCAT2 exon skipping. The findings indicate macrophage reprogramming toward an inflammatory antitumor state and enhanced anti–PD-1 efficacy in gastric cancer, supported by molecular and single-cell analyses.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/disrupting-srsf10-dependent-bcat2-exon-skipping-reprograms-tumor-associated-macrophages-and-enhances-antipd-1-efcacy-in-gastric-cancer/360410/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/disrupting-srsf10-dependent-bcat2-exon-skipping-reprograms-tumor-associated-macrophages-and-enhances-antipd-1-efcacy-in-gastric-cancer/360410.png","ImageObject",300,407,{"name":42,"@type":43},"eBook King","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why do immune checkpoint inhibitors show limited efficacy in many patients?","Question",{"text":63,"@type":64},"About ~30% of solid tumor patients achieve durable responses, while others show primary resistance or acquired resistance after initial response.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do tumor-associated macrophages contribute to impaired immunotherapy in gastric cancer?",{"text":68,"@type":64},"Tumor-associated macrophages include immunosuppressive M2 and pro-inflammatory M1 subsets; M2 cells suppress immune activity via cytokines such as IL-10 and TGF-β, hindering effective anti-tumor immunity.",{"name":70,"@type":61,"acceptedAnswer":71},"What role does alternative splicing play in immunotherapy resistance?",{"text":72,"@type":64},"Alternative splicing is a nuclear process generating mature RNAs from pre-mRNA and is prevalent in multi-exon genes; splicing regulation by SR-family proteins supports investigation of resistance-associated gene signatures.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},360410,1790344300,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962088006270,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nDisrupting SRSF10-dependent BCAT2 exon skipping reprograms tumor-associated macrophages and enhances antiPD-1 efﬁcacy in gastric cancer  \nXiao-Bo Huang 1,2,3,4, Xin-Peng Yang 1,2,3,4, Hua-Long Zheng 1,2,3,4, Ling-Qian Wang 1,2,3,4, Chen-Yang Jiang 1,2,3, Yun-Lin Chen1,2,3, Bin Lin 1,2,3, Yi-Fan Li1,2,3, Xiao-Jing Guo1,2,3, Qiang Huang 1,2,3, You-Xin Gao 1,2,3, Yi Li1,2,3, Xiao-Qian Ye1,2,3, Jia-Bin Wang 1,2,3, Jian-Wei Xie1,2,3, Jian-Xian Lin1,2,3, Chao-Hui Zheng 1,2,3, Chang-Ming Huang 1,2,3 ✉, Qi-Yue Chen 1,2,3 ✉ and Ping Li 1,2,3 ✉  \n© The Author(s) 2026  \nINTRODUCTION  \nImmune checkpoint inhibitors (ICIs) have revolutionized cancer therapeutics, emerging as one of the most promising therapeutic strategies [1, 2] . Despite ~30% of solid tumor patients achieve durable antitumor responses to ICIs treatment, clinical efﬁcacy remains constrained by primary resistance or acquired resistance following initial response [1–4] . Compounding this challenge, gastric cancer (GC) manifests a profoundly heterogeneous malignancy characterized by substantial variability in its responsiveness to immunotherapy [5–9] . This variability underscores the urgent need to decipher the complex molecular underpinnings of ICIs refractoriness.  \nThe immunosuppressive tumor microenvironment (TME), characterized by abundant tumor-associated macrophages (TAMs), constitutes a major impediment to ICIs efﬁcacy in malignancies including GC [10, 11] . As pivotal components, TAMs encompass two functionally distinct subsets: immunosuppressive M2-polarized macrophages and pro-inﬂammatory M1 macrophages [12–14] . M2 macrophages perpetuate immunosuppression by secreting cytokines such as IL-10 and TGF-β, thereby dampening immune cell activity [12–14] . Conversely, M1 macrophages potentiate T-cell-mediated anti-tumor responses via molecules  \nincluding CXCL9 and NOS2, facilitating tumor cell eradication [12–14] . Crucially, the inherent plasticity of macrophages presentsa therapeutic opportunity to reprogram these cells toward a proinﬂammatory, antitumoral M1-like state, transforming immunologically “cold” tumors into “hot” tumors and enhancing ICIs responsiveness in GC [11, 14] .  \nWith advancing comprehension of cancer molecular pathogenesis, there is increasing recognition of the critical function transcriptional reprogramming in both tumor progression and immune evasion [15] . Notably, we emphasize the discovery of a clinically relevant gene signature associated with immunosuppressive therapy resistance, which holds potential for elucidating the dynamic mechanisms underlying immunotherapy resistance in GC: alternative splicing (AS) [16–19] . AS is a nuclear process involving intron excision from pre-mRNA and exon ligation to generate mature RNAs [16–19] . Previous studies revealed that >90% of human multi-exon genes undergo AS, establishing it as a critical post-transcriptional mechanism governing gene expression and cellular fate [17–20] . The serine/arginine-rich (SR) family members act as auxiliary splicing regulators by binding exonic/ intronic splicing enhancers (ESEs/ISEs) or silencers (ESSs/ISSs) near splice sites [19, 21, 22] . Although SR proteins are evolutionarily  \n1Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, PR China. 2Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian, PR China. 3Fujian Key Laboratory of Tumor Microbiology, Fujian Medical University, Fuzhou, Fujian, PR China. 4These authors contributed  \nequally: Xiao-Bo Huang, Xin-Peng Yang, Hua-Long Zheng, Ling-Qian Wang. ✉ email: [hcmlr2002@163.com](hcmlr2002@163.com); [690934662@qq.com](690934662@qq.com); pingli81[1002@163.com](1002@163.com)  \nEdited by Professor Yufang Shi  \nReceived: 1 September 2025 Revised: 11 February 2026 Accepted: 9 March 2026  \nOfﬁcial journal of CDDpress  \nX.-B. Huang et al.  \nPlasma cell  \nEpithelial Mon","cbCaiicZ5QS7yyxq","https://ap.wps.com/l/cbCaiicZ5QS7yyxq","pdf",14652918,13,"English","# Introduction\n## Immune checkpoint inhibitor resistance in solid tumors\n## Gastric cancer heterogeneity and immunotherapy refractoriness\n## Tumor-associated macrophage subsets and macrophage reprogramming\n## Alternative splicing and SRSF10-dependent mechanisms\n## Study focus and supporting analyses","[{\"question\":\"Why do immune checkpoint inhibitors show limited efficacy in many patients?\",\"answer\":\"About ~30% of solid tumor patients achieve durable responses, while others show primary resistance or acquired resistance after initial response.\"},{\"question\":\"How do tumor-associated macrophages contribute to impaired immunotherapy in gastric cancer?\",\"answer\":\"Tumor-associated macrophages include immunosuppressive M2 and pro-inflammatory M1 subsets; M2 cells suppress immune activity via cytokines such as IL-10 and TGF-β, hindering effective anti-tumor immunity.\"},{\"question\":\"What role does alternative splicing play in immunotherapy resistance?\",\"answer\":\"Alternative splicing is a nuclear process generating mature RNAs from pre-mRNA and is prevalent in multi-exon genes; splicing regulation by SR-family proteins supports investigation of resistance-associated gene signatures.\"}]","Disrupting SRSF10-dependent BCAT2 exon skipping reprograms tumor-associated macrophages and enhances antiPD-1 efﬁcacy in gastric cancer | PDF",1790139977,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c4660f4187d590d49af2aa512b2b460.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/05930516bd1619a3d7a7eb0afce5e325.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c56a70f1f0a56d06822c085ccf99fd05.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/076fb798a487fe8c01c0cc5d9f82de58.webp",980,1301]